World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
34407
World Ranking
8625
National Ranking
4450

Overview

Richard Gorlick is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research is primarily focused on fields including Medicine and Biochemistry, Genetics and Molecular Biology, with a specific concentration in Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, and Neurology.

The main topics addressed in their work include:

  • Sarcoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Neuroblastoma Research and Treatments
  • Virus-based gene therapy research
  • Immunotherapy and Immune Responses
  • Lymphoma Diagnosis and Treatment

Recent publications by Richard Gorlick cover several aspects of osteosarcoma and cancer therapy, including:

  • Advancing therapy for osteosarcoma, 2021, Nature Reviews Clinical Oncology
  • Osteosarcoma, 2022, Nature Reviews Disease Primers
  • Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma, 2020, JAMA Oncology
  • Immuno-genomic landscape of osteosarcoma, 2020, Nature Communications
  • The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models, 2021, Clinical Cancer Research

Frequent co-authors in Gorlick's research include:

  • Jonathan Gill
  • Wendong Zhang
  • Katherine A. Janeway
  • Zhongting Zhang
  • Douglas J. Harrison

Richard Gorlick has contributed to publications in several notable journals with multiple works in venues such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • Clinical Cancer Research
  • Nature Medicine

In addition to journal articles, Gorlick has published books through Springer Nature, including:

  • Current Advances in the Science of Osteosarcoma, 2020
  • Current Advances in Osteosarcoma, 2020

Best Publications

  • Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

    Michael S. Isakoff;Stefan S. Bielack;Paul S Meltzer;Richard Gorlick

  • The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.

    Chand Khanna;Xiaolin Wan;Seuli Bose;Ryan Cassaday

  • Biology and Therapeutic Advances for Pediatric Osteosarcoma

    Neyssa Marina;Mark Gebhardt;Lisa Teot;Richard Gorlick

  • Current and future therapeutic approaches for osteosarcoma

    Douglas J. Harrison;David S. Geller;Jonathan D. Gill;Valerae O. Lewis

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder

  • Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Neyssa M Marina;Sigbjørn Smeland;Stefan S Bielack;Mark Bernstein

  • Osteosarcoma: a review of diagnosis, management, and treatment strategies.

    David S. Geller;Richard Gorlick

  • The pediatric preclinical testing program: description of models and early testing results.

    Peter J. Houghton;Christopher L. Morton;Chandra Tucker;Debbie Payne

  • Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Sigbjørn Smeland;Stefan S. Bielack;Jeremy Whelan;Mark Bernstein

  • Advancing therapy for osteosarcoma.

    Jonathan Gill;Richard Gorlick

  • Chemotherapy resistance in osteosarcoma: current challenges and future directions

    Alexander J Chou;Richard Gorlick

  • Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Stefan S. Bielack;Sigbjørn Smeland;Jeremy S. Whelan;Neyssa Marina

  • Dickkopf 3 Inhibits Invasion and Motility of Saos-2 Osteosarcoma Cells by Modulating the Wnt-β-Catenin Pathway

    Bang H. Hoang;Tadahiko Kubo;John H. Healey;Rui Yang

  • Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

    Paul A. Meyers;Richard Gorlick;Glenn Heller;Ephraim Casper

  • Expression of HER2/erbB-2 Correlates With Survival in Osteosarcoma

    Richard Gorlick;Andrew G. Huvos;Glenn Heller;Alex Aledo

  • Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.

    Debabrata Banerjee;Philipp Mayer-Kuckuk;Gina Capiaux;Gina Capiaux;Tulin Budak-Alpdogan

  • Therapy for osteosarcoma: where do we go from here?

    Alexander J. Chou;David S. Geller;Richard Gorlick

  • EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

    J. S. Whelan;S. S. Bielack;N. Marina;S. Smeland

  • New targets and approaches in osteosarcoma.

    Jonathan Gill;Manpreet K. Ahluwalia;Manpreet K. Ahluwalia;David Geller;David Geller;Richard Gorlick;Richard Gorlick

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Meredith Yeager;Weiyin Zhou;Sholom Wacholder

Frequent Co-Authors

Malcolm A. Smith
Malcolm A. Smith National Institutes of Health
Peter J. Houghton
Peter J. Houghton The University of Texas Health Science Center at San Antonio
John M. Maris
John M. Maris Children's Hospital of Philadelphia
C. Patrick Reynolds
C. Patrick Reynolds Texas Tech University Health Sciences Center
Paul A. Meyers
Paul A. Meyers Memorial Sloan Kettering Cancer Center
John H. Healey
John H. Healey Memorial Sloan Kettering Cancer Center
Mark Krailo
Mark Krailo University of Southern California
Andrew G. Huvos
Andrew G. Huvos Memorial Sloan Kettering Cancer Center
Julie M. Gastier-Foster
Julie M. Gastier-Foster Baylor College of Medicine
Holcombe E. Grier
Holcombe E. Grier Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, several related online degrees offer flexible, affordable pathways into healthcare. Medical billing and coding is a popular entry point, allowing students to gain essential administrative skills. For those concerned about tuition, look for medical billing and coding online courses cost to find the most budget-friendly programs.

Nursing remains one of the most in-demand professions in the U.S. Aspiring nurses can take advantage of the cheapest online nursing program options to begin working in patient care more quickly and affordably. For advanced roles, nurse practitioner programs provide an excellent route to higher-paying, responsible positions with expanded clinical authority.

Those aiming for leadership or research roles should consider doctoral studies. Explore online phd nursing programs that combine scientific inquiry, policy, and education. All these paths offer flexible online learning formats, opening up new career opportunities and advancement in the healthcare sector.

Best Scientists Citing Richard Gorlick

Trending Scientists

Recently Published Articles